Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $359.05 | 1.18% | 2.21% | 7.41% | -1.34% | 12.44% | 50.79% | 56.78% | 5.89% | 1,247.28% | $385.22 | $196.45 | 6.79% | 82.77% | 0.98 | 126,000 | -31.89% |
| NVO | NOVO NORDISK A S | $49.23 | -0.28% | 1.01% | -18.87% | 3.53% | -8.41% | -40.20% | -30.96% | 31.12% | 95.75% | $93.80 | $43.08 | 47.52% | 14.28% | 0.67 | 11,281,000 | 14.48% |
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $45.39 | 0.02% | 0.91% | 10.63% | 9.96% | 34.61% | 132.17% | 245.17% | 89.92% | N/A | $46.65 | $18.26 | 2.70% | 148.64% | 0.84 | 256,000 | -53.62% |
| ZVRA | ZEVRA THERAPEUTICS INC | $8.65 | 0.70% | 2.00% | -4.10% | -10.82% | -5.98% | 8.81% | 62.59% | -11.55% | -96.41% | $13.16 | $6.19 | 34.27% | 39.74% | 0.89 | 536,000 | 29.16% |
| CORT | CORCEPT THERAPEUTICS INC | $39.82 | 0.48% | -2.47% | 12.84% | -46.98% | -44.51% | -45.15% | 82.24% | 49.03% | 950.66% | $117.33 | $32.99 | 66.06% | 20.70% | 0.96 | 808,000 | -3.81% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $332.68 | 0.02% | 3.40% | -6.43% | -28.04% | -27.18% | 33.07% | 66.46% | 121.45% | 432.37% | $495.55 | $205.87 | 32.87% | 61.60% | 0.90 | 1,141,000 | -24.54% |
| VCEL | VERICEL CORP | $37.41 | 1.60% | 8.03% | 3.09% | -4.15% | 3.00% | -34.69% | 30.76% | -26.59% | 1,818.46% | $57.73 | $29.24 | 35.19% | 27.94% | 1.49 | 339,000 | -27.10% |
| ARGX | ARGENX SE | $845.35 | 0.21% | 1.29% | 4.41% | -7.97% | 27.83% | 32.29% | 130.78% | 130.81% | N/A | $934.62 | $510.06 | 9.55% | 65.74% | 0.64 | 166,000 | -42.56% |
| GMAB | GENMAB A | $29.16 | -2.80% | -2.99% | -6.93% | -3.83% | 24.51% | 33.95% | -25.73% | -27.95% | 162.70% | $35.43 | $17.24 | 17.70% | 69.19% | 0.73 | 3,054,000 | 0.56% |
| KRYS | KRYSTAL BIOTECH INC | $283.29 | -1.58% | 3.90% | 3.09% | 38.37% | 93.64% | 80.80% | 265.25% | 279.85% | N/A | $298.30 | $122.80 | 5.03% | 130.69% | 1.37 | 525,000 | -37.72% |
| LGND | LIGAND PHARMACEUTICALS INC | $189.94 | 1.30% | 2.14% | -3.37% | -8.26% | 23.93% | 58.30% | 167.97% | 31.09% | 112.29% | $212.49 | $93.58 | 10.61% | 102.97% | 1.16 | 177,000 | 48.74% |
| TECH | BIO-TECHNE CORP | $59.33 | 1.42% | -6.49% | -14.71% | 2.03% | 11.33% | -9.13% | -19.45% | -40.23% | 172.38% | $72.16 | $46.01 | 17.78% | 28.95% | 1.18 | 1,836,000 | -28.25% |
| ADMA | ADMA BIOLOGICS INC | $15.99 | 0.25% | -1.78% | -9.10% | 1.91% | -9.30% | -1.11% | 352.97% | 505.68% | 275.35% | $25.67 | $13.50 | 37.71% | 18.44% | 1.21 | 3,105,000 | 94.18% |
| MNKD | MANNKIND CORP | $5.44 | -1.81% | -5.23% | -0.91% | 7.51% | 42.78% | 0.37% | 3.23% | 2.45% | 18.26% | $6.51 | $3.38 | 16.44% | 60.90% | 1.11 | 2,162,000 | 17.05% |
| ABEO | ABEONA THERAPEUTICS INC | $5.12 | 1.59% | 1.19% | -3.58% | 14.29% | -25.90% | -12.48% | 117.87% | -91.67% | -92.27% | $7.54 | $3.93 | 32.10% | 30.18% | 0.84 | 402,000 | -37.96% |
| HALO | HALOZYME THERAPEUTICS INC | $73.23 | -9.01% | -7.90% | 3.98% | 4.47% | 6.19% | 26.48% | 47.46% | 52.28% | 808.56% | $82.22 | $47.50 | 10.93% | 54.17% | 0.83 | 6,351,000 | 204.75% |
| RPRX | ROYALTY PHARMA PLC | $45.34 | -0.15% | 2.44% | 15.99% | 14.90% | 26.22% | 38.02% | 21.59% | -2.47% | N/A | $46.14 | $29.66 | 1.73% | 52.87% | 0.48 | 2,025,000 | -39.50% |
| VCYT | VERACYTE INC | $36.61 | 1.61% | 1.72% | -12.19% | -5.55% | 21.75% | -9.43% | 61.14% | -47.57% | 501.15% | $50.71 | $22.61 | 27.81% | 61.92% | 1.96 | 679,000 | 19.33% |
| XOMA | XOMA ROYALTY CORP | $24.35 | -0.49% | 4.64% | -6.74% | -25.74% | -23.28% | -3.10% | 16.06% | -33.62% | 52.55% | $39.92 | $18.35 | 39.00% | 32.68% | 0.84 | 69,000 | -31.00% |
| NAGE | NIAGEN BIOSCIENCE INC | $5.00 | -4.94% | -2.15% | -19.48% | -27.11% | -50.59% | -15.40% | 190.70% | -33.51% | 31.23% | $14.69 | $4.93 | 65.96% | 1.52% | 1.38 | 1,015,000 | 46.04% |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.98 | 0.00% | 2.05% | 45.37% | 58.51% | 93.51% | 18.25% | 87.42% | -38.17% | -63.97% | $3.10 | $1.32 | 3.87% | 125.76% | 0.71 | 2,108,000 | 108.71% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.28 | -4.44% | -3.58% | -1.75% | 3.80% | -3.10% | -9.75% | -19.47% | -4.62% | N/A | $40.87 | $25.52 | 13.68% | 38.24% | 0.82 | 1,376,000 | 87.72% |
| CPRX | CATALYST PHARMACEUTICALS INC | $24.29 | -1.42% | 1.50% | 3.89% | 7.19% | 20.07% | 5.93% | 59.28% | 463.57% | 1,907.44% | $26.58 | $19.05 | 8.62% | 27.51% | 1.04 | 1,025,000 | -20.05% |
| AUPH | AURINIA PHARMACEUTICALS INC | $14.31 | 0.00% | -1.38% | -3.25% | -7.68% | 17.10% | 79.10% | 83.93% | -9.83% | 556.42% | $16.54 | $6.55 | 13.48% | 118.47% | 1.11 | 736,000 | 30.50% |
| APLS | APELLIS PHARMACEUTICALS INC | $22.20 | 2.92% | -0.49% | 8.45% | 12.52% | -18.83% | -21.22% | -62.05% | -50.61% | N/A | $30.48 | $16.10 | 27.17% | 37.89% | 0.99 | 1,347,000 | -11.61% |
| CRMD | CORMEDIX INC | $7.17 | -0.55% | -3.50% | 4.22% | -28.83% | -45.27% | -32.55% | 74.45% | -55.88% | -24.92% | $17.43 | $5.60 | 58.86% | 28.04% | 1.06 | 1,173,000 | -17.80% |
| REGN | REGENERON PHARMACEUTICALS INC | $792.16 | -0.17% | 1.69% | 7.96% | 9.21% | 38.03% | 16.49% | 6.11% | 66.06% | 104.53% | $821.11 | $476.49 | 3.53% | 66.25% | 0.60 | 676,000 | -3.15% |
| UTHR | UNITED THERAPEUTICS CORP | $476.05 | -1.32% | 0.04% | 1.70% | -0.11% | 51.56% | 27.69% | 86.50% | 181.14% | 272.23% | $519.99 | $266.98 | 8.45% | 78.31% | 0.44 | 218,000 | -34.53% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.83 | 3.14% | 2.52% | 9.80% | 14.16% | 7.64% | -4.67% | -41.65% | -25.75% | -17.42% | $73.51 | $50.76 | 15.89% | 21.81% | 0.73 | 1,864,000 | 35.56% |
| ACAD | ACADIA PHARMACEUTICALS INC | $23.20 | 1.09% | 3.25% | -11.75% | -2.52% | -7.42% | 17.53% | 24.60% | -53.99% | 20.71% | $28.35 | $13.40 | 18.17% | 73.13% | 0.93 | 1,091,000 | -39.59% |
| VRTX | VERTEX PHARMACEUTICALS INC | $470.31 | -1.47% | 1.97% | 6.39% | 7.99% | 20.63% | 1.77% | 60.80% | 124.14% | 442.83% | $519.68 | $362.50 | 9.50% | 29.74% | 0.57 | 1,663,000 | -3.37% |
| INVA | INNOVIVA INC | $23.66 | -0.80% | 5.25% | 21.02% | 8.18% | 13.86% | 31.23% | 92.67% | 101.71% | 97.66% | $24.01 | $16.52 | 1.46% | 43.22% | 0.40 | 685,000 | -26.26% |
| EXEL | EXELIXIS INC | $44.47 | 0.88% | 3.56% | 1.58% | 4.27% | 17.77% | 30.03% | 154.84% | 99.78% | 992.63% | $49.62 | $32.38 | 10.38% | 37.34% | 0.63 | 3,268,000 | 9.74% |
| MDXG | MIMEDX GROUP INC | $5.22 | 1.16% | 0.19% | -3.15% | -22.32% | -27.40% | -36.50% | 16.00% | -46.79% | -33.33% | $8.46 | $4.89 | 38.30% | 6.75% | 1.30 | 454,000 | -4.42% |
| INCY | INCYTE CORP | $102.99 | 1.81% | 4.20% | 0.36% | -0.87% | 21.28% | 44.51% | 31.21% | 26.29% | 45.02% | $112.29 | $53.56 | 8.28% | 92.29% | 0.56 | 1,607,000 | -15.64% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.